Table 2.
Variable |
Control (n = 38) |
Migraine type | P † | P ‡ | |
---|---|---|---|---|---|
MWA (n = 36) |
MWoA (n = 40) |
||||
RNFL-G | 102.18 ± 8.11 | 88.38 ± 18.01 | 84.8 ± 28.12 | 0.075 | 0.139 |
RNFL-T | 76.53 ± 13.27 | 68.34 ± 18.43 | 71.6 ± 14.74 | 0.111 | |
RNFL-TS | 137.84 ± 19.55 | 119.41 ± 30.28 | 114.2 ± 49.52 | 0.179 | |
RNFL-NS | 113.84 ± 20.4 | 95.34 ± 24.83 | 92.4 ± 41.25 | 0.111 | |
RNFL-N | 76.24 ± 11.34a | 67.97 ± 15.33b | 63.2 ± 16.5b | 0.018 | |
RNFL-Nİ | 116.84 ± 23.62a | 98.1 ± 21.89b | 91.6 ± 37.64b | 0.003 | |
RNFL-Tİ | 141.11 ± 23.49 | 120.86 ± 35.83 | 109.2 ± 46.74 | 0.100 |
P †: significance value after one-way analysis of variance (ANOVA). P ‡: significance value after one-way multivariate analysis of variance (MANOVA). Values are expressed as mean ± SD. Different superscripts (a, b) in a row indicate statistically significant difference among groups.